Alikhan A, Sayed C, Alavi A. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part II: topical, intralesional, and systemic medical management. J Am Acad Dermatol. 2019;81(1):91–101.

Article  PubMed  PubMed Central  Google Scholar 

Shi VY, Hsiao JL, Lowes M, Hamzavi IH, editors. A comprehensive guide to hidradenitis suppurativa. Philadelphia: Elsevier; 2022.

Google Scholar 

Hunt A, Qian V, Olds H, Daveluy S. The current clinical trial landscape for hidradenitis suppurativa: a narrative review. Dermatol Ther (Heidelb). 2023;13(7):1391–407.

Article  PubMed  PubMed Central  Google Scholar 

Westerkam L, Sayed C. A review of the current landscape of hidradenitis suppurativa treatment development. J Drugs Dermatol. 2023;22(10):1021–6.

Article  PubMed  Google Scholar 

Zouboulis CC, Bechara FG, Benhadou F, Bettoli V, Bukvić Mokos Z, Del Marmol V, et al. European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: treatment. J Eur Acad Dermatol Venereol. 2024. https://doi.org/10.1111/jdv.20472.

Article  PubMed  Google Scholar 

Alikhan A, Sayed C, Alavi A. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part I: diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol. 2019;81(1):76–90.

Article  PubMed  PubMed Central  Google Scholar 

Sayed CJ, Hsiao JL, Okun MM, Hidradenitis Suppurativa Foundation Women’s Health Subcommittee. Clinical epidemiology and management of hidradenitis suppurativa. Obstet Gynecol. 2021;137(4):731–46.

Article  PubMed  PubMed Central  Google Scholar 

Revuz J. Hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2009;23(9):985–98.

Article  CAS  PubMed  Google Scholar 

Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juhász I, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015;29(4):619–44.

Article  CAS  PubMed  Google Scholar 

Revuz JE, Jemec GBE. Diagnosing hidradenitis suppurativa. Dermatol Clin. 2016;34(1):1–5.

Article  CAS  PubMed  Google Scholar 

Frew JW, Lowes MA, Goldfarb N. Global harmonization of morphological definitions in hidradenitis suppurativa for a proposed glossary. JAMA Dermatol. 2021;157(4):449–55.

Article  PubMed  PubMed Central  Google Scholar 

Daxhelet M, Suppa M, White J, Benhadou F, Thorlacius LR, Jemec GBE, et al. Proposed definitions of typical lesions in hidradenitis suppurativa. Dermatology. 2020;236(5):431–8.

Article  PubMed  Google Scholar 

Lipsker D, Severac F, Freysz M, Sauleau E, Boer J, Emtestam L, et al. The ABC of Hidradenitis suppurativa: a validated glossary on how to name lesions. Dermatology. 2016;232(2):137–42.

Article  PubMed  Google Scholar 

Hurley H, Roenigk RK, Roenigk HH. Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach. Dermatol Surg. 1989:729–739.

Daoud M, Suppa M, Benhadou F, Daxhelet M, Njimi H, White J, et al. Overview and comparison of the clinical scores in hidradenitis suppurativa: a real-life clinical data. Front Med (Lausanne). 2023;10:1145152.

Article  PubMed  PubMed Central  Google Scholar 

Kimball AB, Kirby J, Ingram JR, Tran T, Pansar I, Ciaravino V, et al. Burden of hidradenitis suppurativa: a systematic literature review of patient reported outcomes. Dermatol Ther (Heidelb). 2024;14(1):83–98.

Article  PubMed  PubMed Central  Google Scholar 

Sisic M, Kirby JS, Boyal S, Plant L, McLellan C, Tan J. Development of a quality-of-life measure for hidradenitis suppurativa. J Cutan Med Surg. 2017;21(2):152–5.

Article  PubMed  Google Scholar 

Orenstein LAV, Amah A, Shaw FM, Zhang C, Swerlick RA, Chen SC. Validation of the three-item Skindex-Mini among hidradenitis suppurativa patients with diverse racial backgrounds. J Cutan Med Surg. 2020;24(5):457–60.

Article  PubMed  Google Scholar 

Garg A, Malviya N, Strunk A. Comorbidity screening in hidradenitis suppurativa: evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations. J Am Acad Dermatol. 2022;86(5):1092–101.

Article  PubMed  Google Scholar 

Shah M, Sachdeva M, Melendez-Gonzalez M, Piguet V, Sayed C. Hidradenitis suppurativa and chromosomal abnormalities: a case report and systematic review of the literature. Int J Dermatol. 2021;60(3):261–71.

Article  PubMed  Google Scholar 

Shih T, Shi V, Hsiao JL. Treatment stacking: optimizing therapeutic regimens for hidradenitis suppurativa. Cutis. 2021;108(4):176–8.

PubMed  Google Scholar 

Jemec GB, Wendelboe P. Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J Am Acad Dermatol. 1998;39(6):971–4.

Article  CAS  PubMed  Google Scholar 

Clemmensen OJ. Topical treatment of hidradenitis suppurativa with clindamycin. Int J Dermatol. 1983;22(5):325–8.

Article  CAS  PubMed  Google Scholar 

Katoulis A, Efthymiou O, Liakou A, Pappa G, Kanelleas A, Koumaki D, et al. Resorcinol 10% as a promising therapeutic option for mild hidradenitis suppurativa: a prospective, randomized, open study. Skin Appendage Disord. 2023;9(6):438–43.

Article  PubMed  PubMed Central  Google Scholar 

Aarts P, Reeves JL, Ardon CB, Zee HH, Prens EP. Clindamycin-benzoyl peroxide gel compared with clindamycin lotion for hidradenitis suppurativa: a randomized controlled assessor-blinded intra-patient pilot study. Dermatology. 2023;239(4):670–4.

Article  CAS  PubMed  Google Scholar 

Hargis A, Yaghi M, Maskan Bermudez N, Lev-Tov H. Clascoterone in the treatment of mild hidradenitis suppurativa. J Am Acad Dermatol. 2024;90(1):142–4.

Article  CAS  PubMed  Google Scholar 

Porter MJ, et al. Efficacy and safety of ruxolitinib cream in patients with hidradenitis suppurativa (Hurley Stage I and II): results from a randomised, double-blind, vehicle-controlled phase 2 study. LB2, 2024 AAD Annual Meeting, 8–12 March, San Diego, USA.

An JH, Moon SJ, Shin JU, Kim DH, Yoon MS, Lee HJ. Clindamycin mono-therapy of hidradenitis suppurativa patients: a single-center retrospective study. Ann Dermatol. 2021;33(6):515–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Masson R, Seivright J, Shih T. Trimethoprim/sulfamethoxazole and cephalexin combination therapy in hidradenitis suppurativa patients: a series of 16 cases. JAAD Case Rep. 2023;5(37):1–4.

Google Scholar 

Nosrati A, Ch’en PY, Torpey ME, Shokrian N, Ball G, Benesh G, et al. Efficacy and durability of intravenous ertapenem therapy for recalcitrant hidradenitis suppurativa. JAMA Dermatol. 2024;160(3):312–8.

Article  PubMed  PubMed Central  Google Scholar 

Sanchez-Diaz M, Diaz-Calvillo P, Rodriguez-Pozo JÅ, Arias-Santiago S, Molina-Leyva A. Effectiveness and safety of acitretin for the treatment of hidradenitis suppurativa, predictors of clinical response: a cohort study. Dermatology. 2023;239(1):52–9.

Article  CAS  PubMed  Google Scholar 

Huang CY, Shah SA, Cochrane M, Douglas A, Yang S. Hidradenitis suppurativa disease control associated with type of hormonal contraceptive use. Clin Exp Dermatol. 2024;49(4):375–8.

Article  PubMed  Google Scholar 

Stellon AJ, Wakeling M. Hidradenitis suppurativa associated with use of oral contraceptives. BMJ. 1989;298(6665):28–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Montero-Vilchez T, Valenzuela-Amigo A, Cuenca-Barrales C, Arias-Santiago S, Leyva-García A, Molina-Leyva A. The role of oral contraceptive pills in hidradenitis suppurativa: a cohort study. Life (Basel). 2021;11(7):697.

CAS  PubMed  PubMed Central  Google Scholar 

Hambly R, Kearney N, Hughes R, Fletcher JM, Kirby B. Metformin treatment of hidradenitis suppurativa: effect on metabolic parameters, inflammation, cardiovascular risk biomarkers, and immune mediators. Int J Mol Sci. 2023;24(8):6969. https://doi.or